Evidence map›Paper›PMID 37565261›Full record

ArticleEuropean journal of translational myology2023

Proteomic profiling of the brain from the

Sandra Murphy, Thomas Schmitt-John, Paul Dowling, Michael Henry, Paula Meleady, Dieter Swandulla, Kay Ohlendieck

Open access · goldAbstract read
In one paragraph

Article in European journal of translational myology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. GARP Complex in Golgi Physiology.Sub-cellular biochemistry · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 5 countries.

Sandra MurphyCharles River Laboratories, Chesterford Research Park, Saffron Walden. sandra.murphy@crl.com.
Thomas Schmitt-JohnPlasmatreat GmbH, Steinhagen. t.schmitt-john@plasmatreat.de.
Paul DowlingDepartment of Biology, Maynooth University, National University of Ireland, Maynooth, Co. Kildare, Ireland; Kathleen Lonsdale Institute for Human Health Research, Maynooth University, Maynooth, Co. Kildare. paul.dowling@mu.ie.
Michael HenryNational Institute for Cellular Biotechnology, Dublin City University, Dublin. michael.henry@dcu.ie.
Paula MeleadyNational Institute for Cellular Biotechnology, Dublin City University, Dublin. paula.meleady@dcu.ie.
Dieter SwandullaInstitute of Physiology, Medical Faculty, University of Bonn, Bonn. swandulla@uni-bonn.de.
Kay OhlendieckDepartment of Biology, Maynooth University, National University of Ireland, Maynooth, Co. Kildare, Ireland; Kathleen Lonsdale Institute for Human Health Research, Maynooth University, Maynooth, Co. Kildare. kay.ohlendieck@mu.ie.
Dublin City University · IENational University of Ireland, Maynooth · IECharles River Laboratories (Netherlands) · NLPlasmatreat (Germany) · DEUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The wobbler mouse is a widely used model system of amyotrophic lateral sclerosis and exhibits progressive neurodegeneration and neuroinflammation in association with skeletal muscle wasting. This study has used wobbler brain preparations for the systematic and mass spectrometric determination of proteome-wide changes. The proteomic characterization of total protein extracts from wobbler specimens was carried out with the help of an Orbitrap mass spectrometer and revealed elevated levels of glia cell marker proteins, i.e., glial fibrillary acidic protein and the actin-binding protein coronin. In contrast, the abundance of the actin-binding protein neurabin and the scaffolding protein named piccolo of the presynaptic cytomatrix were shown to be reduced. The increased abundance of glial fibrillary acidic protein, which is frequently used in neuropathological studies as a marker protein of glial scar formation, was confirmed by immunoblotting. In analogy, the proteomic profiling of the brain from another established murine model of motor neuron disease, the SOD1mouse, also showed increased levels of this intermediate filament protein. This suggests that neurodegenerative processes are associated with astrogliosis in both the wobbler and SOD1 brain.

Identifiers

PMID37565261
PMCPMC10583141
OpenAlexW4385644719

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.